SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Free Report) was the recipient of a large drop in short interest in October. As of October 31st, there was short interest totalling 100 shares, a drop of 98.1% from the October 15th total of 5,200 shares. Based on an average trading volume of 13,200 shares, the short-interest ratio is presently 0.0 days.
SAB Biotherapeutics Price Performance
Shares of SAB Biotherapeutics stock traded up $0.00 during trading on Wednesday, hitting $0.05. 3,789 shares of the stock traded hands, compared to its average volume of 19,583. The firm’s fifty day moving average is $0.04 and its 200-day moving average is $0.04. SAB Biotherapeutics has a 52 week low of $0.01 and a 52 week high of $0.19.
SAB Biotherapeutics Company Profile
See Also
- Five stocks we like better than SAB Biotherapeutics
- What is the Dow Jones Industrial Average (DJIA)?
- Rocket Lab is the Right Stock for the Right Time
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What Do S&P 500 Stocks Tell Investors About the Market?
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for SAB Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SAB Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.